Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Procedure guideline for breast scintigraphy.

BIBLIOGRAPHIC SOURCE(S)

  • Society of Nuclear Medicine. Procedure guideline for breast scintigraphy. Version 2.0. Reston (VA): Society of Nuclear Medicine; 2004 Jun 2. 4 p.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Procedure guideline for breast scintigraphy, 1.0. J Nucl Med 1999 Jul;40(7):1233-5.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Background Information and Definitions

Breast scintigraphy is performed after intravenous administration of 99mTc-sestamibi and includes planar and/or single-photon emission computed tomography (SPECT).

Examples of Clinical or Research Applications

  1. Evaluate breast cancer in patients in whom mammography is nondiagnostic, equivocal, or difficult to interpret (e.g., the presence of scar tissue, mammographically dense breast tissue, implants, or severe dysplastic disease)
  2. Assist in identifying multicentric and multifocal carcinomas in patients with tissue diagnosis of breast cancer
  3. May be useful in the evaluation of the effectiveness of neoadjuvant chemotherapy for breast carcinoma

Procedure

The detailed procedure recommendations in the guideline address the following areas: patient preparation; information pertinent to performing the procedure (i.e., important data that the physician should have about the patient at the time the exam is performed and interpreted); precautions; information regarding the radiopharmaceutical (i.e., ranges of administered activity, organ receiving the largest radiation dose, effective dose), image acquisition; interventions; processing; interpretation/reporting; quality control, and sources of error.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting the recommendations is not specifically stated.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Society of Nuclear Medicine. Procedure guideline for breast scintigraphy. Version 2.0. Reston (VA): Society of Nuclear Medicine; 2004 Jun 2. 4 p.

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1999 Jul (revised 2004 Jun 2)

GUIDELINE DEVELOPER(S)

Society of Nuclear Medicine, Inc - Medical Specialty Society

SOURCE(S) OF FUNDING

Society of Nuclear Medicine (SNM)

GUIDELINE COMMITTEE

Task Force

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Authors: Iraj Khalkhali, MD (Harbor-UCLA Medical Center, Torrance, CA); Gina Caravaglia, MD (Harbor-UCLA Medical Center, Torrance, CA); Hani H. Abdel-Nabi, MD, PhD (University of Buffalo, Buffalo, NY); Patrick J. Peller, MD (Woodburn Nuclear Medicine, Annandale, VA); Raymond Taillefer, MD (Hospital Hotel-Dieu de Montreal, Montreal, Quebec, Canada); Penny R. Vande Streek, DO (Sutter Roseville Medical Center, Roseville, CA); Christophe Van de Wiele, MD (Universitair Ziekenhuis, Ghent, Belgium)

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Procedure guideline for breast scintigraphy, 1.0. J Nucl Med 1999 Jul;40(7):1233-5.

GUIDELINE AVAILABILITY

Electronic copies: Available from the Society of Nuclear Medicine (SNM) Web site.

Print copies: Available from SNM, Division of Health Care Policy, 1850 Samuel Morse Dr, Reston, VA 20190-5316; Phone: 1-800-513-6853 or 1-703-326-1186; Fax: 703-708-9015; E-Mail: ServiceCenter@snm.org.

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

Print copies: Available from SNM, Division of Health Care Policy, 1850 Samuel Morse Dr, Reston, VA 20190-5316; Phone: 1-800-513-6853 or 1-703-326-1186; Fax: 703-708-9015; E-Mail: ServiceCenter@snm.org.

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on July 20, 1999. It was verified by the guideline developer as of August 5, 1999. This NGC summary was updated by ECRI on April 28, 2005. The updated information was verified by the guideline developer on June 30, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo